RGS16 has also been associated in the anti-proliferative effect of retinoic acid in neuroblastoma cells and the cytotoxic effect of histone deacetylase inhibitor Vorinostat in triple negative breast cancers [67, 68]. The gene discussed is RGS16; the disease is neuroblastoma.